Press release
Digital Therapeutics Market Size to Boost USD 72.65 Billion By 2032 | CAGR 32.0% - Published by Emergen Research
The global Digital Therapeutics Market size was USD 4.60 Billion in 2022 and is expected to register a rapid revenue CAGR of 32.0% during the forecast period. Increasing use of smartphones and tablets and access to the Internet and rising healthcare industries, government funding's, and prevalence of chronic diseases are key factors driving market revenue growth.The digital therapeutics market represents a rapidly evolving sector within healthcare, offering novel solutions for the prevention, management, and treatment of various medical conditions using digital technologies and software applications. Digital therapeutics, also known as software-as-a-medical-device (SaMD), deliver evidence-based interventions to patients through mobile apps, wearable devices, and online platforms, aiming to improve health outcomes, enhance patient engagement, and optimize healthcare delivery. These interventions may include cognitive behavioral therapy, mindfulness training, medication adherence monitoring, and personalized health coaching, among others.
The report offers these individuals a vivid description of the competitive spectrum of the global Digital Therapeutics Market The study audits various winning strategies adopted by the market leaders to maintain the competitive edge worldwide. This adds more clarity to the research. Resource charts, tables and graphical images are included to make decisive statistics self-explanatory.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2786
Drivers of the Digital Therapeutics Market :
The growth of the digital therapeutics market is driven by several factors, including the increasing prevalence of chronic diseases, rising healthcare costs, advancements in digital health technologies, and the growing acceptance of digital interventions by healthcare providers, payers, and patients. Chronic conditions such as diabetes, hypertension, obesity, and mental health disorders pose significant challenges to healthcare systems worldwide, driving the demand for innovative solutions to improve disease management and patient outcomes. Moreover, the COVID-19 pandemic has accelerated the adoption of telemedicine and remote monitoring solutions, further propelling the growth of the digital therapeutics market.
Challenges and Restraints
Despite the promising growth prospects, the digital therapeutics market faces certain challenges and constraints. One of the primary concerns is the need for robust clinical evidence to demonstrate the efficacy, safety, and cost-effectiveness of digital therapeutic interventions, particularly for regulatory approval and reimbursement. Moreover, ensuring user engagement, adherence, and long-term behavior change poses challenges for developers and healthcare providers, as patient retention and sustained health outcomes are essential for the success of digital therapeutics. Additionally, regulatory uncertainty, data privacy concerns, and interoperability issues may hinder market adoption and integration with existing healthcare systems.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2786
The report also discusses the key players involved in the market such as:
Omada Health Inc., GAIA AG, CureApp, Inc., CANARY HEALTH, Happify, Inc., Kaia Health, 2Morrow Inc., Medtronic, Voluntis, Welldoc, Inc., Livongo Health, Inc., Mango Health, and DairoHealth Corp
The report provides a thorough estimation of the overall impact of the pandemic on the Digital Therapeutics Market and its vital segments. The report also discusses the impact of the pandemic across different regions of the market. It also offers a current and future assessment of the impact of the pandemic on the Digital Therapeutics Market
Digital Therapeutics Latest Industry Updates
In March 2022, Tufts Health Plan and Spectrum Health Systems collaborated with Pear Therapeutics to test FDA. with approved digital Therapeutics to assist people with substance use disorders and improvise their recovery journeys.
In February 2022, DynamiCare Health Inc., a digital therapeutics company, received Breakthrough Device Designation for DCH-001 from the U.S. Food and Drug Administration (FDA) to treat tobacco use disorder complicating pregnancy and childbirth.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2786
Digital Therapeutics Market Segment Analysis :
For the purpose of this report, Emergen Research has segmented the global digital therapeutics market on the basis of product, therapy, application, sales channel, and region:
Product Outlook (Revenue, USD Billion; 2019-2032)
Software
Devices
Therapy Outlook (Revenue, USD Billion; 2019-2032)
Curative
Preventive
Application Outlook (Revenue, USD Billion; 2019-2032)
Diabetes
Obesity
Cardiovascular Disorder
Respiratory Diseases
Smoking Cessation
Medication Adherence
Gastrointestinal Disorder
Rehabilitation and Patient Care
Insomnia
Others
Sales Channel Outlook (Revenue, USD Billion; 2019-2032)
Business to Business (B2B)
Business to Consumer (B2C)
Caregivers
Patients
Providers
Employers
Others
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Benelux
Russia
Rest of Europe
Asia Pacific
China
Japan
South Korea
India
ASEAN Countries
Oceania
Rest of APAC
Latin America
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
Israel
Turkey
South Africa
Rest of Middle East & Africa
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/digital-therapeutics-market
Contact Us:
Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Custom Intelligence services https://www.emergenresearch.com/custom-intelligence
Growth Consulting Services https://www.emergenresearch.com/growth-consultant
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Digital Therapeutics Market Size to Boost USD 72.65 Billion By 2032 | CAGR 32.0% - Published by Emergen Research here
News-ID: 3472964 • Views: …
More Releases from Emergen Research

Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…

Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…

Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…

Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…